Biological markers of sexual activity: Tools for improving measurement in HIV/sexually transmitted infection prevention research

Sexually Transmitted Diseases

Volumn 40, Issue 6, 2013, Pages 447-452

  Gallo, Maria F ^a   Steiner, Markus J ^b   Hobbs, Marcia M ^c   Warner, Lee ^a   Jamieson, Denise J ^a   MacAluso, Maurizio ^d  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; PLASMA PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN SEMENOGELIN; UNCLASSIFIED DRUG; Y CHROMOSOME DNA;

ANAL INTERCOURSE; COITUS; CONDOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PROSTITUTION; REVIEW; SELF REPORT; SEMEN ANALYSIS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

BIOLOGICAL MARKERS; FEMALE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; MALE; SELF REPORT; SEMEN; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES;

EID: 84878853695     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31828b2f77     Document Type: Review

References (34)

1. Stuart GS, Grimes DA. Social desirability bias in famil-planning studies: A neglected problem. Contraception 2009; 80:108-112.
2. Noar SM, Cole C, Carl-le K. Condom use measurement in 56 studies of sexual risk behavior: Review and recommendations. Arch Sex Behav 2006; 35:327-345.
3. Lipovsek V, Longfield K, Buszin J. Can follow-up study questions about correct and consistent condom use reduce respondent overreporting among groups at high risk? An anal-sis of datasets from six countries. Reprod Health 2010; 7:9.
4. Hara M, Inorre T, Fukuyama T. Some ph-sicochemical characteristics of gamma-seminoprotein, an antigenic component specific for human seminal plasma. Nippon Hoigaku Zasshi 1971; 25: 322-324.
5. Macaluso M, Lawson ML, Warner DL. Repl-to: The use of prostate-specific antigen as a criterion for condom effectiveness. Am J Epidemiol 2005; 162:705.
6. Graves HC, Sensabaugh GF, Blake ET. Postcoital detection of a male-specific semen protein. Application to the investigation of rape. N Engl J Med 1985; 312:338-343.
7. Lawson ML, Maculuso M, Bloom A, et al. Objective markers of condom failure. Sex Transm Dis 1998; 25:427-432.
8. Macaluso M, Lawson L, Akers R, et al. Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. Contraception 1999; 59:195-201.
9. Gallo MF, Snead MC, Black CM, et al. Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studies. Contraception 2012; pii:S0010-7824(12)00885-2.
10. Hobbs MM, Steiner MJ, Rich KD, et al. Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: Implications for qualitative research. Sex Trans Dis 2009; 36:501-506.
11. Snead MC, Kourtis AP, Black CM, et al. Effect of topical vaginal products on the detection of prostate specific antigen, a biomarker of semen exposure, using ABAcards. Contraception 2012; pii: S0010-7824(12)00966-3.
12. Brotman RM, Melendez JH, Smith TD, et al. Effect of menses on clearance of Y-chromosome in vaginal fluid: Implications for a biomarker of recent sexual activit-. Sex Transm Dis 2010; 37:1-4.
13. Pequegnat W, Fishbein M, Celentano D, et al. NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: A position statement. Sex Transm Dis 2000; 27:127-132.
14. Gear-CW, Tchupo JP, Johnson L, et al. Respondent perspectives on self-report measures of condom use. AIDS Educ Prev 2003; 15:499-515.
15. Aho J, Koushik A, Diakité SL, et al. Biological validation of selfreported condom use among sex workers in Guinea. AIDS Behav 2010; 14:1287-1293.
16. Gallo MF, Behets FM, Steiner MJ, et al. Prostate-specific antigen to ascertain reliabilit-of self-reported coital exposure to semen. Sex Transm Dis 2006; 33:476-479.
17. Gallo MF, Behets FM, Steiner MJ, et al. Validity of self-reported 'safe sex' among female sex workers in Mombasa, KenyaVPSA analysis. Int J STD AIDS 2007; 18:33-38.
18. Minnis AM, Steiner MJ, Gallo MF, et al. Biomarker validation of reports of recent sexual activity: Results of a randomized controlled stud-in Zimbabwe. Am J Epidemiol 2009; 170:918-924.
19. Mensch BS, Hewett PC, Abbott S, et al. Assessing the reporting of adherence and sexual activit-in a simulated microbicide trial in South Africa: An interview mode experiment using a placebo gel. AIDS Behav 2011; 15:407-421.
20. Jadack RA, Yuenger J, Ghanem KG, et al. Polymerase chain reaction detection of Y-chromosome sequences in vaginal fluid of women accessing a sexuall-transmitted disease clinic. Sex Transm Dis 2006; 33:22-25.
21. Rose E, Diclemente RJ, Wingood GM, et al. The validity of teens' and-oung adults' self-reported condom use. Arch Pediatr Adolesc Med 2009; 63:61-64.
22. Langhaug LF, Sherr L, Cowan FM. How to improve the validity of sexual behaviour reporting: Systematic review of questionnaire deliver-modes in developing countries. Trop Med Int Health 2010; 15:362-381.
23. Turner AN, De Kock AE, Meehan-Ritter A, et al. Many vaginal microbicide trial participants acknowledged the-had misreported sensitive sexual behavior in face-to-face interviews. J Clin Epidemiol 2009; 62:759-765.
24. Gallo MF, Sobel JD, Rompalo AM, et al. Discordance between spermatozoa detection and self-reported semen exposure. Sex Transm Dis 2011; 38:909-912.
25. Johnson WD, Diaz RM, Flanders WD, et al. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database S-st Rev 2008; 16:CD001230.
26. Macaluso M, Blackwell R, Jamieson DJ, et al. Efficacy of the male latex condom and of the female pol-urethane condom as barriers to semen during intercourse: A randomized clinical trial. Am J Epidemiol 2007; 166:88-96.
27. Galvao LW, Oliveira LC, Diaz J, et al. Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: A randomized trial. Contraception 2005; 71:130-136.
28. Anderson C, Gallo MF, H-lton-Kong T, et al. Randomized controlled trial on the effectiveness of counseling messages for avoiding unprotected sexual intercourse during STI and RTI treatment among female STI clinic patients. Sex Transm Dis 2013; 40:105-110.
29. van der Straten A, Cheng H, Moore J, et al. The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav 2009; 13:564-572.
30. Thomsen SC, Gallo MF, Ombidi W, et al. Randomised controlled trial on whether advance knowledge of prostate-specific antigen testing improves participant reporting of unprotected sex. Sex Transm Infect 2007; 83:419-420.
31. Chernesky MA, Hook EW 3rd, Martin DH, et al. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlam-dia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis 2005; 32:729-733.
32. Morey TE, Wasdo S, Wishin J, et al. Feasibilit-of a breath test for monitoring adherence to vaginal administration of antiretroviral microbicide gels. J Clin Pharmacol 2012. [Epub ahead of print].
33. Kristal AR, Peters U, Potter JD. Is it time to abandon the food frequenc-questionnaire? Cancer Epidemiol Biomarkers Prev 2005; 14:2826-2828.
34. Dietz PM, Homa D, England LJ, et al. Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am J Epidemiol 2011; 173:355-359.